ORAGENICS, INC. Restricted Cash and Cash Equivalents, Current
ORAGENICS, INC. (OGEN) had Restricted Cash and Cash Equivalents, Current of $0 as of 2013-12-31, per its 10-K filed 2014-02-28.
Discontinued › Balance Sheet › Assets › Assets, Current › Restricted Cash and Cash Equivalent, Current
us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue · last filed 2014-02-28
- 2013-12-31: Restricted Cash and Cash Equivalents, Current $0.00.
- 2013-03-31: Restricted Cash and Cash Equivalents, Current $25.77K.
- 2012-12-31: Restricted Cash and Cash Equivalents, Current $61.76K.
- 2012-09-30: Restricted Cash and Cash Equivalents, Current $144.59K.
| Period end | Restricted Cash and Cash Equivalents, Current |
|---|---|
| 2013-12-31 | $0.00 10-K · filed 2014-02-28 |
| 2013-03-31 | $25.77K 10-Q · filed 2013-05-15 |
| 2012-12-31 | $61.76K 10-K · filed 2014-02-28 |
| 2012-09-30 | $144.59K 10-Q · filed 2012-11-14 |
| 2012-06-30 | $195.39K 10-Q · filed 2012-08-10 |
| 2012-03-31 | $294.10K 10-Q · filed 2012-05-15 |
| 2011-12-31 | $264.96K 10-K · filed 2013-03-26 |
| 2011-09-30 | $382.92K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $440.76K 10-Q · filed 2011-08-05 |
| 2010-12-31 | $475.66K 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |